Published in Blood Weekly, February 10th, 2000
The mission of the newly created organization, named the Plasma Protein Therapeutics Association (PPTA), is to promote the availability of high quality, safe, and effective plasma protein therapeutics. Every year, over 1 million people worldwide receive plasma therapeutics in treating diseases and serious medical conditions such as bleeding disorders, immune system deficiencies, burns, and shock.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.